BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 26427157)

  • 1. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
    Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
    Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis.
    Ding M; Li Y; Wang H; Lv Y; Liang J; Wang J; Li C
    Int J Clin Exp Med; 2015; 8(9):15432-40. PubMed ID: 26629032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
    Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
    Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs used as novel biomarkers for detecting cancer metastasis.
    Han C; Yu H; Zhang L; Li X; Feng Y; Xin H
    Tumour Biol; 2015 Mar; 36(3):1755-62. PubMed ID: 25366141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
    Shi HB; Yu JX; Yu JX; Feng Z; Zhang C; Li GY; Zhao RN; Yang XB
    World J Surg Oncol; 2017 Aug; 15(1):147. PubMed ID: 28774300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
    Cui Z; Lin D; Song W; Chen M; Li D
    Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of microRNA expressions in diagnosing uterine cancer and predicting lymph node metastasis.
    Hou C; Tan G; Feng S
    Tumour Biol; 2014 Nov; 35(11):10789-98. PubMed ID: 25077926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
    Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
    Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
    Wan J; Wu W; Che Y; Kang N; Zhang R
    Dis Esophagus; 2016 Jul; 29(5):412-20. PubMed ID: 25789723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis.
    Wei D; Wan Q; Li L; Jin H; Liu Y; Wang Y; Zhang G
    Mol Neurobiol; 2015; 51(3):1452-61. PubMed ID: 25081587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
    Chen L; Jin H
    Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
    Gao J; Fan YZ; Gao SS; Zhang WT
    Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
    Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
    Ye Q; Wang J; Xu D; Liu Y; Zhang D; Ye J; Li H
    Expert Rev Anticancer Ther; 2022 Dec; 22(12):1357-1369. PubMed ID: 36374119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.